Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of the Society for Gynecologic Investigation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by La Marca, A.
Right arrow Articles by Volpe, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by La Marca, A.
Right arrow Articles by De Leo, V.
Right arrow Articles by Giulini, S.
Right arrow Articles by Orvieto, R.
Right arrow Articles by Malmusi, S.
Right arrow Articles by Giannella, L.
Right arrow Articles by Volpe, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Menopause
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced Menopause

Antonio La Marca, MD

Institute of Obstetrics and Gynecology, Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy; Institute of Obstetrics and Gynecology, Policlinico Le Scotte, University of Siena, Siena, Italy and Institute of Obstetrics and Gynecology, Rabin Medical Center, University of Tel Aviv, Tel Aviv, Israel; Institute of Obstetrics and Gynecology, Policlinico di Modena, Largo del Pozzo, 41100 Modena, italy antlamarca{at}libero.it

Vincenzo De Leo, MD

Simone Giulini, MD

Raoul Orvieto, MD

Stefania Malmusi, MD

Luca Giannella, MD

Annibale Volpe, MD

Institute of Obstetrics and Gynecology, Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy; Institute of Obstetrics and Gynecology, Policlinico Le Scotte, University of Siena, Siena, Italy and Institute of Obstetrics and Gynecology, Rabin Medical Center, University of Tel Aviv, Tel Aviv, Israel

Objective: The objectives of this study were: (1) to determine anti-Mullerian hormone (AMH) levels in menopausal women, and (2) to confirm the source of AMH in cycling women and its disapperance after the removal of the source.

Methods: An observational and prospective study was conducted.

Results: A total of 47 women were recruited for the study. The study population consisted of the following groups of patients: (A) women of late reproductive age (n= 24; mean age ± SD, 44 ± 2.8 years); (B) menopausal women (n= 14; mean age, 56 ± 4 years); (C) regularly cycling women undergoing surgical menopause (n= 9; mean age, 43 ± 4 years). Blood samples were obtained from all patients. In patients undergoing surgery, blood samples were obtained before and after surgery. AMH was undetectable in 13 of 14 postmenopausal women, whereas it was undetectacle in only two of 24 women of late reproductive age. A significant negative correlation has been found between AMH and age or follicle-stimulating hormone (FSH) in women of late reproductive age. In women who were candidates for oophorectomy, samples were obtained 3-5 days after surgery. AMH was undetectable after the surgery in all women.

Conclusions: We found that AMH levels decreased in women in the late reproductive period and that menopause and ovariectomy in regularly cycling women are associated to undetectable AMH in serum. These observations confirm that the ovary could be the only source of AMH in women and that it is a novel marker for ovarian aging.

Key Words: Anti-mullerian hormone • late reproductive period • menopause • ovarian aging • follicle-stimulating hormone

Journal of the Society for Gynecologic Investigation, Vol. 12, No. 7, 545-548 (2005)
DOI: 10.1016/j.jsgi.2005.06.001


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
D. B. Seifer, D. T. MacLaughlin, and H. S. Cuckle
Serum mullerian-inhibiting substance in Down's syndrome pregnancies
Hum. Reprod., January 11, 2007; (2007) del497v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A. La Marca and A. Volpe
The Anti-Mullerian hormone and ovarian cancer
Hum. Reprod. Update, January 9, 2007; (2007) dml060v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Meduri, N. Massin, J. Guibourdenche, A. Bachelot, O. Fiori, F. Kuttenn, M. Misrahi, and P. Touraine
Serum anti-Mullerian hormone expression in women with premature ovarian failure
Hum. Reprod., January 1, 2007; 22(1): 117 - 123.
[Abstract] [Full Text] [PDF]